NIH-funded research R01 grant

Reprogramming blood-vessel lining cells in inherited brain aneurysms

Official title: Endothelial Cell Reprogramming in Familial Intracranial Aneurysm

Funded at Yale University · NIH-11258496 · Data updated 2026-11-12

This project aims to find out whether fixing gene-related changes in the cells that line brain arteries can lower aneurysm risk in people with a family history.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2028
Funding year2026
Award (this year)$589,159
NIH project number5R01NS127469-04
Project IDNIH-11258496 on NIH RePORTER

Who could benefit from this research

Could help

Adults (21+) with a personal diagnosis of intracranial aneurysm or a strong family history of brain aneurysms, especially families with multiple affected relatives, are the ideal candidates.

Less likely to help

People without a hereditary form of aneurysm or those needing immediate clinical treatment to stop an active leak are unlikely to receive direct clinical benefit from this lab-focused genetic research right away.

What this research studies

You may be asked to share family and medical history and provide a blood sample for genetic sequencing. Researchers will compare genes from families with multiple aneurysms to find rare mutations, including changes in WBP11 and PPIL4. They will study how those mutations change the behavior of the cells that line brain blood vessels using lab-grown human cells and animal models to see why vessel walls weaken and bleed. The team hopes to use those findings to point to tests or new treatments that could help prevent aneurysm formation or rupture.

Why it matters

Potential benefit: If successful, this work could identify people at higher hereditary risk and point to new ways to protect vessel walls or prevent aneurysm rupture.

How similar studies have gone: Previous genetic and animal studies have linked gene changes to aneurysm biology, but the roles of WBP11 and PPIL4 are newly identified and targeting them in patients remains untested.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Gunel, Murat — Yale University
  • Study coordinator: Gunel, Murat

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.